Home/Filings/4/0001181431-13-017571
4//SEC Filing

REID CLIFFORD A 4

Accession 0001181431-13-017571

CIK 0001361103other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 6:48 PM ET

Size

16.3 KB

Accession

0001181431-13-017571

Insider Transaction Report

Form 4
Period: 2013-03-14
REID CLIFFORD A
DirectorPresident, CEO & Director
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-03-18$1.65/sh50,666$83,5990 total
    Exercise: $1.50Exp: 2019-12-27Common Stock (50,666 underlying)
  • Disposition to Issuer

    Common Stock, par value $0.001

    2013-03-14$3.15/sh310,200$977,1300 total(indirect: By Trust)
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-03-18$1.65/sh3,090$5,0990 total
    Exercise: $1.50Exp: 2019-11-12Common Stock (3,090 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-03-18$0.14/sh250,000$35,0000 total
    Exercise: $3.01Exp: 2022-04-01Common Stock (250,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2013-03-18$1.65/sh341,667$563,7510 total
    Exercise: $1.50Exp: 2020-02-23Common Stock (341,667 underlying)
Footnotes (5)
  • [F1]These shares were tendered to Beta Acquisition Corporation (the "Purchaser"), a wholly-owned subsidiary of BGI-Shenzhen, pursuant to Purchaser's offer to purchase all of the outstanding shares of the Issuer at a price of $3.15 per share (the "Per Share Merger Consideration"), without interest, subject to the terms described in the Offer to Purchase for Cash filed with the Securities and Exchange Commission on September 25, 2012 and in the related Letter of Transmittal, together with any amendments or supplements thereto, and the Agreement and Plan of Merger, dated as of September 15, 2012 (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, on March 18, 2013, the Issuer completed its merger (the "Merger") with BGI-Shenzhen, whereby the Issuer became a wholly owned subsidiary of BGI-Shenzhen.
  • [F2]No shares are held by the Clifford A Reid Living Trust, Dated September 3, 1997, Clifford A. Reid, Trustee following the Merger.
  • [F3]In accordance with the terms of the Merger Agreement, each option to acquire shares of the Issuer (whether vested or unvested) that was outstanding immediately prior to the consummation of the Merger was canceled in exchange for the right to receive an amount in cash equal to the product of the number of shares of Issuer common stock subject to the option and the excess, if any, of the Per Share Merger Consideration over the exercise price per share of each respective award, less any required withholding taxes. The award, which provided for vesting in 48 successive, equal monthly installments measured from August 12, 2009, accelerated and became fully vested upon the consummation of the Merger, pursuant to the terms of the option agreement and the Merger Agreement.
  • [F4]In accordance with the terms of the Merger Agreement, each option to acquire shares of the Issuer (whether vested or unvested) that was outstanding immediately prior to the consummation of the Merger was canceled in exchange for the right to receive an amount in cash equal to the product of the number of shares of Issuer common stock subject to the option and the excess, if any, of the Per Share Merger Consideration over the exercise price per share of each respective award, less any required withholding taxes. The award, which provided for vesting in 48 successive, equal monthly installments measured from April 1, 2009, accelerated and became fully vested upon the consummation of the Merger, pursuant to the terms of the option agreement and the Merger Agreement.
  • [F5]In accordance with the terms of the Merger Agreement, each option to acquire shares of the Issuer (whether vested or unvested) that was outstanding immediately prior to the consummation of the Merger was canceled in exchange for the right to receive an amount in cash equal to the product of the number of shares of Issuer common stock subject to the option and the excess, if any, of the Per Share Merger Consideration over the exercise price per share of each respective award, less any required withholding taxes. The award, which provided for vesting in 48 successive, equal monthly installments measured from April 2, 2012, accelerated and became fully vested upon the consummation of the Merger, pursuant to the terms of the option agreement and the Merger Agreement.

Documents

1 file

Issuer

COMPLETE GENOMICS INC

CIK 0001361103

Entity typeother

Related Parties

1
  • filerCIK 0001134041

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 6:48 PM ET
Size
16.3 KB